Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Here’s a look at the top five short squeeze candidates for the week of Oct. 3 based on the Fintel short squeeze leaderboard.
Greenwich LifeSciences: Clinical stage biopharmaceutical company Greenwich LifeSciences (NASDAQ:GLSI) tops the short squeeze leaderboard, moving up five positions from last week’s report. The company was previously in the top five short squeeze candidates, with 24.8% of the float short. New data shows 27.4% of the float short and a cost to borrow of 11.4%.
Blue Apron: Meal kit company Blue Apron Holdings (NYSE:APRN) moves up 18 places with one of the biggest moves of the week to rank second on the leaderboard. Data shows 40% of the float short and a cost to borrow of 33.3%. The stock has been mentioned heavily as a top short squeeze candidate.
Related Link: Apple Overtakes Tesla As The Most Shorted Stock
SurgePays: Fintech company SurgePays Inc (NASDAQ:SURG) moves up four positions to rejoin the top five short squeeze candidates, ranking third for the week. Data shows 56.4% of the float short and a cost to borrow of 7.1%.
Syros Pharmaceuticals: Biopharmaceutical company Syros Pharmaceuticals (NASDAQ:SYRS) ranked fourth on the leaderboard. The move comes after the stock was mentioned by Benzinga as a stock to watch with a recent surge up the leaderboard, up 244 positions to eighth place. Data shows 43.2% of the float short and a cost to borrow of 11.9%. Benzinga recently reported that 21.5% of the float was short, and the stock had a cost to borrow of 10.2%.
TDH Holdings: Pet food company TDH Holdings Inc (NASDAQ:PETZ) is the lone carryover from last week’s top five short squeeze ideas, staying at fifth place for a second straight week. Data shows 16.0% of the float short, down from last week’s reported 31.2%. The cost to borrow on shares of 68.6% is up from last week’s 58.6%.
